Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 83, Issue 2, Pages 227-230Publisher
WILEY
DOI: 10.1038/sj.clpt.6100479
Keywords
-
Categories
Ask authors/readers for more resources
The pharmaceutical industry is facing tremendous pressure, not only from payers but as a result of public perception, regulatory hurdles, and the intricacies of research and development (R&D). The latter two are significant in that they affect the number of drugs that may be registered by regulatory authorities, the time to discover and develop drugs, and the cost of drug development. Because drug development has been stagnant in terms of innovation, there exists huge potential for innovation. Failure to innovate drug development will render the big pharma model unsustainable.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available